Suicide Clinical Trial - Proximal Risk for Suicide in Adolescents

Status Recruiting

Clinical Trial Summary

The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents.

Clinical Trial Description

Suicide rates have exponentially increased, and it is now the 2nd leading cause of death in adolescence, accounting for over 1.2 million annual emergency department (ED) visits. After an ED visit or attempt, up to 20% of adolescents will have a second attempt within 12 months, and almost half will have a repeat ED visit. This proposal's overall objectives are to investigate physiologic parameters and biometric data from wearable technology that is temporally related to suicidal behavior and develop a personalized, predictive tool that can improve outpatient identification of adolescent patients with suicidality before a crisis develops requiring an ED visit. The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents. To attain the overall objectives, I will pursue the following specific aims: (i) To evaluate whether HRV, combined with patient-specific risk factors, can be used to detect dynamic changes in suicide severity among a prospective cohort of acutely suicidal adolescents, (ii) To utilize machine learning to determine whether there is a temporal relationship/signature in the raw PPG signal before or immediately after changes in suicide severity reporting combined with patient-specific risk factors to develop a prediction tool for suicidality risk. These aims will be accomplished in three years through a prospective observational study enrolling acutely suicidal adolescents in the ED and an inpatient psychiatric unit. Ultimately, such knowledge can offer unique opportunities for early detection, just-in-time interventions, and support over 1.2 million suicidal adolescents presenting to EDs nationally. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06400810
Study type	Observational
Source	Oregon Health and Science University
Contact	David Sheridan, MD
Phone	503-494-1691
Email	sheridda@ohsu.edu
Status	Recruiting
Phase
Start date	June 15, 2023
Completion date	July 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04127292` - Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome	N/A
Recruiting	`NCT06079853` - Nurse Suicide: Physiologic Sleep Health Promotion Trial	N/A
Recruiting	`NCT05423483` - Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents	Phase 2
Completed	`NCT03272048` - Identifying Effective Approaches to Counseling on Firearm Safety	N/A
Completed	`NCT05514587` - Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
Enrolling by invitation	`NCT05639426` - Preventing Youth Violence Through Building Equitable Communities	N/A
Completed	`NCT03703128` - Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study
Completed	`NCT03646903` - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk	N/A
Not yet recruiting	`NCT05558332` - Youth Nominated Support Team	N/A
Not yet recruiting	`NCT06349915` - A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents	N/A
Completed	`NCT02718248` - Ottawa Suicide Prevention in Men Pilot Study	N/A
Completed	`NCT02094898` - Ketamine for Depression and Suicide Risk	Phase 2
Completed	`NCT01594138` - Linguistic Characteristics of Suicidal Patients in the Emergency Department	N/A
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT02228044` - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment	N/A
Completed	`NCT00604097` - Preventing Youth Suicide in Primary Care: A Family Model	Phase 3
Completed	`NCT00387855` - An Evaluation of the SOS (Suicide Prevention) Program	N/A
Recruiting	`NCT03519802` - Evaluation of Cognitive Function in a Suicidal Crisis
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT03030924` - Wearable Suicidal Early Warning System for Adolescents

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.